American Century Companies’s Epizyme, Inc EPZM Stock Holding History

American Century Companies’s Portfolio EPZM Stock Details EPZM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-10,295	Closed	-$129K	–	1354
2019 Q2	$129K	Buy	+10,295	New	+$132K	﹤0.01%	1247
2016 Q4	–	Sell	-51,456	Closed	-$506K	–	1431
2016 Q3	$506K	Buy	51,456 +852	+2%	+$7.78K	﹤0.01%	1264
2016 Q2	$518K	Buy	+50,604	New	+$564K	﹤0.01%	1243

Other funds holding EPZM

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

CCM

Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return

American Century Companies's EPZM Position: Q3 2019 in Review

American Century Companies sold out of Epizyme, Inc (EPZM) in Q3 2019, closing a stake of 10,295 shares — an estimated $129K sold.

American Century Companies first reported a position in EPZM in Q2 2016 and held it in 3 quarters. The position peaked at $518K in Q2 2016. 115 funds tracked by Wall St. Rank hold EPZM as of Q3 2019.

American Century Companies reported no remaining Epizyme, Inc position as of Q3 2019 after selling out during the quarter.
American Century Companies sold 10,295 Epizyme, Inc shares in Q3 2019, an estimated $129K.
American Century Companies first reported a position in Epizyme, Inc in Q2 2016 and held it in 3 quarters.
American Century Companies's Epizyme, Inc position peaked at $518K in Q2 2016.
115 funds tracked by Wall St. Rank held Epizyme, Inc as of Q3 2019.

Based on American Century Companies's 13F filing for Q3 2019, filed 13 Nov 2019.